Copyright
©The Author(s) 2019.
World J Clin Cases. Jul 26, 2019; 7(14): 1732-1752
Published online Jul 26, 2019. doi: 10.12998/wjcc.v7.i14.1732
Published online Jul 26, 2019. doi: 10.12998/wjcc.v7.i14.1732
Table 3 Eighth edition of the TNM classification of the AJCC/UICC (2017-2018)[30] - Distal cholangiocarcinoma
Primary tumor (pT) | Regional lymph nodes (pN) | Distant metastasis (pM) | Stage grouping |
TX: Primary tumor cannot be assessed | NX: Regional lymph nodes cannot be assessed | Stage 0: Tis N0 M0; Stage I: T1 N0 M0; Stage IIA: T1 N1 M0 or T2 N0 M0; Stage IIB: T2 N1 M0 or T3 N0-1 M0; Stage IIIA: T1-3 N2 M0; Stage IIIB: T4 N0-2 M0 | |
T0: No evidence of primary tumor | N0: No regional lymph node metastasis | M0: No distant metastasis | |
Tis: Carcinoma in situ / high grade dysplasia | |||
T1: tumor invades the bile duct wall with a depth less than 5 mm | N1: Metastasis in one to three regional lymph nodes | M1: Distant metástasis | |
T2: Tumor invades the bile duct wall with a depth of 5 - 12 mm | N2: Metastasis in four or more regional lymph nodes | ||
T3: Tumor invades the bile duct wall with a depth greater than 12 mm | |||
T4: Tumor invades the celiac axis, superior mesenteric artery or common hepatic artery |
- Citation: Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, Durá AB, Suárez P, Iranzo I, Gil-Raga M, Burgos CB, Sempere J. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases 2019; 7(14): 1732-1752
- URL: https://www.wjgnet.com/2307-8960/full/v7/i14/1732.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i14.1732